Navigation Links
Studies of Drug Resistance May Lead to Individual Therapy for Rare,Cancers

WASHINGTON, January 29, 2007 /PRNewswire-USNewswire/ -- Rear Admiral Timothy Ziemer (U.S. Navy, retired), the President's Malaria Coordinator, announced his intent to name Dr. Bernard Nahlen to serve as Deputy Coordinator of the President's Malaria Initiative (PMI). Dr. Nahlen is a Commissioned Officer in the U.S. Public Heath Service and has most recently served as Senior Advisor, Monitoring and Evaluation, at the Global Fund to Fight AIDS, Tuberculosis and Malaria.

As Deputy Coordinator, Dr. Nahlen will assist the Coordinator in directing the PMI, an historic $1.2 billion, five-year initiative announced by President Bush in 2005 to control malaria in Africa. His specific responsibilities will include serving as the Senior Technical Advisor to the Coordinator providing guidance on malaria technical issues and program interventions; assisting in country programs, program facilitation, policy coordination, coherence and implementation among all U.S. Government (USG) agencies and other recipients of USG funds for malaria prevention and treatment.

The goal of the PMI is to assist national malaria control programs to cut malaria-related deaths by 50 percent in fifteen target countries in Africa. This goal will be achieved by reaching 85 percent of the most vulnerable groups -- children under five years of age and pregnant women -- with proven and effective prevention and treatment control measures. PMI uses a comprehensive approach to prevent and treat malaria supporting four key areas; indoor spraying of homes with insecticides, insecticide-treated mosquito nets, lifesaving anti-malarial drugs, and treatment to prevent malaria in pregnant women. The initiative is a collaborative USG effort led by the U.S. Agency for International Development (USAID), in conjunction with the Department of Health and Human Services (Centers for Disease Control and Prevention), the Department of State, the White House, and others.

Dr. Nahlen was born in Little Rock, Arkansas, where he graduated from medical school after completing undergraduate studies at the University of Notre Dame. He completed a residency in Family Practice at the University of California at San Francisco before joining the Centers for Disease Control and Prevention in 1986 as an Epidemic Intelligence Officer assigned to the Malaria Branch. In 1989 he completed a second residency in Preventive Medicine and was later served as Deputy Director of the Los Angeles County AIDS Epidemiology Program.

For more information about USAID's malaria programs and the PMI, please visit: http://www.usaid.gov/our_work/global_health/id/malaria/index.html

Public Information: 202-712-4810

CONTACT: U.S. Agency for International Development Press Office:+1-202-712-4320

Web site: http://www.usaid.gov//

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Related medicine technology :

1. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
2. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
3. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
4. Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
5. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
6. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
7. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
8. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
9. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
10. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
11. Neurogen Proprietary Insomnia Compound Data for Two Studies Presented at Associated Professional Sleep Societies Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... WOONSOCKET, R.I. , April 20, 2017 /PRNewswire/ ... (NYSE: CVS), today unveiled a new store design ... new assortment of healthier food, health-focused products and ... the store to help customers discover new offerings. ... represent the next evolution of the customer experience ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 2017 , ... Ushio America proudly introduces the new ... solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts so ... lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s easy ...
(Date:4/28/2017)... Md. (PRWEB) , ... April 28, 2017 , ... ... Association of America (UCAOA) and College of Urgent Care Medicine will host industry ... workshops, sessions and speakers will help those in the industry adapt to the ...
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at ... ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled in ... activity and sleep monitoring solutions for the global scientific community. The company’s new ...
(Date:4/28/2017)... ... 28, 2017 , ... Rob Lowe is a popular actor that has been ... to an educational purpose as the host of the “Informed” series. The program focuses ... recent episode, the series focuses on thyroid cancer. , Although thyroid cancer is an ...
(Date:4/27/2017)... ... April 27, 2017 , ... Healthcare companies are trying ... will rapidly reject an outdated healthcare executive resume. , “If you’re a healthcare executive ... executive resume and wondering if it’s as ready as you are for a new ...
Breaking Medicine News(10 mins):